gadofosveset trisodium has been researched along with contrast agent p792 in 2 studies
| Studies (gadofosveset trisodium) | Trials (gadofosveset trisodium) | Recent Studies (post-2010) (gadofosveset trisodium) | Studies (contrast agent p792) | Trials (contrast agent p792) | Recent Studies (post-2010) (contrast agent p792) |
|---|---|---|---|---|---|
| 265 | 32 | 145 | 37 | 3 | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corot, C; Gagneur, G; Port, M; Robert, P; Violas, X | 1 |
| Corot, C; Gagneur, G; Port, M; Raynal, I; Robert, P; Violas, X | 1 |
2 other study(ies) available for gadofosveset trisodium and contrast agent p792
| Article | Year |
|---|---|
Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol.
Topics: Animals; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Heterocyclic Compounds; Iron; Magnetic Resonance Angiography; Magnetite Nanoparticles; Male; Organometallic Compounds; Oxides; Rabbits | 2003 |
How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
Topics: Animals; Contrast Media; Gadolinium; Heterocyclic Compounds; Injections, Intravenous; Magnetic Resonance Angiography; Meglumine; Organometallic Compounds; Rabbits | 2005 |